|
Progesterone receptor, %
|
|
Total plasma Apolipoprotein A1, mg/dL
|
1.326 e-01
|
0.002
|
|
ILDL Free Cholesterol, mg/dL
|
−6.625 e-03
|
0.062
|
|
ILDL Phospholipids, mg/dL
|
−1.015 e-02
|
0.076
|
|
HDL Cholesterol, mg/dL
|
9.019 e-02
|
8.522 e-06
|
|
HDL Free Cholesterol, mg/dL
|
1.918 e-02
|
0.002
|
|
HDL Phospholipids, mg/dL
|
1.206 e-01
|
1.138 e-04
|
|
HDL Apolipoprotein A1, mg/dL
|
1.393 e-01
|
1.198 e-04
|
|
VLDL4 Cholesterol, mg/dL
|
−1.227 e-02
|
0.068
|
|
VLDL4 Free Cholesterol, mg/dL
|
−5.829 e-03
|
0.085
|
|
VLDL4 Phospholipids, mg/dL
|
−1.138 e-02
|
0.056
|
|
HDL1 Cholesterol, mg/dL
|
4.957 e-02
|
0.014
|
|
HDL1 Phospholipids, mg/dL
|
6.670 e-02
|
0.012
|
|
HDL1 Apolipoprotein A1, mg/dL
|
7.637 e-02
|
0.022
|
|
HDL1 Apolipoprotein A2, mg/dL
|
7.235 e-03
|
0.041
|
|
HDL2 Free Cholesterol, mg/dL
|
3.600 e-03
|
0.040
|
|
HDL2 Phospholipids, mg/dL
|
2.240 e-02
|
0.009
|
|
HDL2 Apolipoprotein A1, mg/dL
|
2.479 e-02
|
0.012
|
|
HDL3 Phospholipids, mg/dL
|
2.549 e-02
|
0.011
|
|
HDL3 Apolipoprotein A1, mg/dL
|
2.906 e-02
|
0.016
|
|
Tumor grade 1–3
|
|
Total plasma Triglycerides, mg/dL
|
−2.694 e-03
|
0.011
|
|
HDL Apolipoprotein A1, mg/dL
|
−1.807 e-03
|
0.056
|
|
Ki67 %
|
|
HDL Cholesterol, mg/dL
|
−3.252 e-02
|
0.060
|
|
HDL2 Cholesterol, mg/dL
|
−7.904 e-03
|
0.083
|
|
Estrogen receptor, %
|
No significant results
|
|
Nodal metastasis, no
|
